Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
Janssen Research & Development, LLC
Philip J Mease; Proton Rahman; Alice B Gottlieb; Alexa P Kollmeier; Elizabeth C Hsia; Xie L Xu; Shihong Sheng; Prasheen Agarwal; Bei Zhou; Yanli Zhuang; Désirée van der Heijde; Iain B McInnes; DISCOVER-2 Study Group
Clinical Biostatistics, Janssen Research and Development, Spring House, PA, USA. ; Clinical Biostatistics, Janssen Research and Development, Spring House, PA, USA.